In Silico Design of Inhibitors for beta-Secretase: Implications for Alzheimer’s Disease

Order of Publishing in Issue: 
Volume :7
Issue :1
January, 2013
Page No: 
S. Sai Madhukar [1], Anand Solomon [2], Viswanath Das [3], K. Anil Kumar [4] and S. Krupanidhi [6]*
[1] Department of Health Informatics, Karolinska Institute of Medical Sciences, Stockholm, Sweden
[2] Sankar Foundation Research Institute, Vishakapatnam 530047, India
[3] School of Biological Sciences and Centre for Biodiscovery, Victoria University of Wellington, Wellington, New Zealand
[4] Tata Chemicals Ltd, Innovation Center, Pune 412108, India, 6 Department of Biotechnology, Vignan University, Vadlamudi 522213. India.

Abstract:  β-secretase is regarded as one of the best characterized targets for Alzheimer’s disease therapy. β-secretase 1 protease plays an important role in cleaving amyloid precursor protein and further the formation of pathogenic β-amyloid plaques in the brain, thereby causing Alzheimer’s disease. The present work reports the docking studies of a series of analogues based derivatives of phenyl-piperazine, cyclic urea, N-phenyl-1-arylamide and Nphenylbenzenesulfonamide. The structure of âsecretase 1 complexed with a ligand, 2-amino- 6-propylpyrimidin-4(3H)-one was retrieved from Protein Data Bank and used in the present study. All the derivatives and clinically used drugs for Alzheimer’s disease, such as, tacrine, razadyne, exelon and aricept were energy minimized and docked with the receptor. The docked positions of all derivatives were compared with tacrine as the standard drug. Four of the derivatives showed better docking score and identical hydrogen bonds with that of tacrine.

β-secretase, amyloid precursor protein, β-amyloid plaques, phenyl-piperazine, cyclic urea, N-phenyl-1-arylamide, Nphenylbenzenesulfonamide.
Paper-10.pdf1.34 MB

To download full text articles and issues in PDF at no cost.All you have to do is fill out a brief registration form. It's easy and it's free. At any time, you may request removal of your contact information from our database.
Click here to Register | Click here if you have already registered

2018 ABAP Awards

Invitation for Nominations to 2019 ABAP Awards
The Association of Biotechnology and Pharmacy invites nominations for the following awards from the eligible talented people with proven track record and achievements on or before August 31, 2019 in the prescribed format.



User login